12/05/2026
RevitalVision Reports Breakthrough Evidence for Improving Vision Across Multiple Eye Conditions.
The growing body of clinical evidence for RevitalVision supports the integration of perceptual learning into routine clinical practice.
A news release published in Ophthalmology Management Journal reports on the findings, which are based on six randomized controlled trials completed in 2025- including three published in leading peer-reviewed ophthalmology journals.
The studies highlight meaningful improvements in visual acuity, contrast sensitivity, and binocular function that demonstrate the brain’s ability to adapt through synaptic and functional neural plasticity. A seventh study further confirmed the long-term stability of visual improvements in patients with amblyopia over a five-year period.
Read the full article here: https://lnkd.in/duf7QWzA
To learn more about the RevitalVision program and the clinical research behind it, visit: https://lnkd.in/dPBz9jZS
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.